Cargando…
Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition
BACKGROUND: Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well exp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921224/ https://www.ncbi.nlm.nih.gov/pubmed/31885479 http://dx.doi.org/10.1016/j.jsps.2019.10.002 |
_version_ | 1783481113980698624 |
---|---|
author | Micháliková, Dominika Tyukos Kaprinay, Barbara Lipták, Boris Švík, Karol Slovák, Lukáš Sotníková, Ružena Knezl, Vladimír Gaspárová, Zdenka |
author_facet | Micháliková, Dominika Tyukos Kaprinay, Barbara Lipták, Boris Švík, Karol Slovák, Lukáš Sotníková, Ružena Knezl, Vladimír Gaspárová, Zdenka |
author_sort | Micháliková, Dominika |
collection | PubMed |
description | BACKGROUND: Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well explored. We decided to test effect of rutin compared to the effect of the standard drug atorvastatin. METHODS: As a model of metabolic syndrome we used males of hypertriacylglycerolemic rats in combination with high-fat-high-fructose diet. Rutin (100 mg/kg) and atorvastatin (50 mg/kg) were administered orally daily for 5 weeks. RESULTS: We determined biochemical parameters from blood: HDL-cholesterol, LDL-cholesterol, total cholesterol, triacylglycerols. Relaxation and contraction response of aorta was measured to determine vessel dysfunctions and possible predisposition to cardiovascular disease. The negative influence on cognitive functions could be associated with the development of metabolic cognitive syndrome. Therefore we aimed to monitor spatial memory by Morris water maze test. Both rutin and atorvastatin had a tendency to decrease levels of serum triacylglycerols, but only atorvastatin significantly reduced levels od LDL-cholesterol and increased HDL-cholesterol levels. Both compounds significantly reduced the phenylephrine-induced contractile response of the aorta and improved the relaxation response. Further, treated animals learned better compared to untreated rats in the Morris water maze. CONCLUSION: Based on our results we can assume that atorvastatin and rutin had positive effect on spatial memory and vessel reactivity. Atorvastatin optimized lipid profile of blood serum. |
format | Online Article Text |
id | pubmed-6921224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69212242019-12-27 Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition Micháliková, Dominika Tyukos Kaprinay, Barbara Lipták, Boris Švík, Karol Slovák, Lukáš Sotníková, Ružena Knezl, Vladimír Gaspárová, Zdenka Saudi Pharm J Article BACKGROUND: Metabolic syndrome is a cluster of metabolic risk factors. The clear causes of its development are not known yet and there is no comprehensive treatment of this disease. There is a trend to use natural substances in the treatment of various diseases, but their effects need to be well explored. We decided to test effect of rutin compared to the effect of the standard drug atorvastatin. METHODS: As a model of metabolic syndrome we used males of hypertriacylglycerolemic rats in combination with high-fat-high-fructose diet. Rutin (100 mg/kg) and atorvastatin (50 mg/kg) were administered orally daily for 5 weeks. RESULTS: We determined biochemical parameters from blood: HDL-cholesterol, LDL-cholesterol, total cholesterol, triacylglycerols. Relaxation and contraction response of aorta was measured to determine vessel dysfunctions and possible predisposition to cardiovascular disease. The negative influence on cognitive functions could be associated with the development of metabolic cognitive syndrome. Therefore we aimed to monitor spatial memory by Morris water maze test. Both rutin and atorvastatin had a tendency to decrease levels of serum triacylglycerols, but only atorvastatin significantly reduced levels od LDL-cholesterol and increased HDL-cholesterol levels. Both compounds significantly reduced the phenylephrine-induced contractile response of the aorta and improved the relaxation response. Further, treated animals learned better compared to untreated rats in the Morris water maze. CONCLUSION: Based on our results we can assume that atorvastatin and rutin had positive effect on spatial memory and vessel reactivity. Atorvastatin optimized lipid profile of blood serum. Elsevier 2019-12 2019-10-11 /pmc/articles/PMC6921224/ /pubmed/31885479 http://dx.doi.org/10.1016/j.jsps.2019.10.002 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Micháliková, Dominika Tyukos Kaprinay, Barbara Lipták, Boris Švík, Karol Slovák, Lukáš Sotníková, Ružena Knezl, Vladimír Gaspárová, Zdenka Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
title | Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
title_full | Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
title_fullStr | Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
title_full_unstemmed | Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
title_short | Natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
title_sort | natural substance rutin versus standard drug atorvastatin in a treatment of metabolic syndrome-like condition |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921224/ https://www.ncbi.nlm.nih.gov/pubmed/31885479 http://dx.doi.org/10.1016/j.jsps.2019.10.002 |
work_keys_str_mv | AT michalikovadominika naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT tyukoskaprinaybarbara naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT liptakboris naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT svikkarol naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT slovaklukas naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT sotnikovaruzena naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT knezlvladimir naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition AT gasparovazdenka naturalsubstancerutinversusstandarddrugatorvastatininatreatmentofmetabolicsyndromelikecondition |